Marek Malik
Elsevier Science
e druk, 2020
9780128177280
Sex and Cardiac Electrophysiology
Differences in Cardiac Electrical Disorders Between Men and Women
Specificaties
Gebonden, blz.
|
Engels
Elsevier Science |
e druk, 2020
ISBN13: 9780128177280
Rubricering
Verwachte levertijd ongeveer 9 werkdagen
Samenvatting
Sex and Cardiac Electrophysiology: Differences in Cardiac Electrical Disorders Between Men and Women is a comprehensive investigation into all aspects of sex differences in cardiac electrophysiology. As there are substantial differences between female and male patients in physiology, pathology triggering factors, disease progression, clinical approaches and treatment outcome, this book provides a comprehensive examination. In cardiology, the differences between women and men are more recognized, hence this title summarizes these important differences, providing the essential information needed for clinical specialists and researchers involved in the design and implementation of clinical studies.
Specificaties
Inhoudsopgave
<p>Introduction<br>1. Distinction between sex and gender<br>2. What is sex good for?</p> <p>Cellular and Tissue Electrophysiology<br>3. Sex differences in cardiac ion channels<br>4. Atrial and ventricular tissue electrophysiology<br>5. Cardiac conduction system</p> <p>Electrocardiography<br>6. Morphology of normal resting electrocardiogram<br>7. QRS duration<br>8. Sex differences in QRS fractionation and slurring abnormalities<br>9. QT interval and QT/RR relationship<br>11. T wave morphology and ventricular gradient<br>12. T wave alternans<br>13. Sex-specific definitions of electrocardiographic abnormalities</p> <p>Cardiac Autonomic Regulation<br>14. Baseline autonomic characteristics<br>15. Cardiac autonomic responses to provocative stimuli<br>16. Circadian pattern of autonomic status</p> <p>Effects of Sex Hormones<br>17. Electrophysiological cellular effects of sex hormones<br>18. Development of electrocardiographic sex differences during puberty<br>19. Electrophysiologic changes during menstrual cycle<br>20. Electrocardiographic changes after heart transplantation<br>21. Cardiac rhythm changes during menopause</p> <p>Channelopathies<br>22. Congenital long QT syndrome<br>23. Congenital short QT syndrome<br>24. Brugada syndrome</p> <p>Drug-Induced Electrophysiology Abnormalities<br>25. Mechanisms of drug-induced QT interval prolongation<br>26. Mechanisms and incidence of Torsade de Pointes tachycardia</p> <p>Training and Sport<br>27. Electrophysiological adaptations to endurance and strength training<br>28. Exercise-based cardiac rehabilitation <br>29. Arrhythmias due to athletic training</p> <p>Cardiomyopathies and Inherited Disorders<br>30. Hypertrophic cardiomyopathy<br>31. Dilated cardiomyopathy<br>32. Arrhythmogenic right ventricular cardiomyopathy<br>33. Catecholaminergic polymorphic ventricular tachycardia<br>34. Cardiac electrophysiology in sex chromosome aneuploidies<br>35. Takotsubo syndrome</p> <p>Supraventricular Tachycardias<br>36. Supraventricular ectopies<br>37. Focal supraventricular tachycardia<br>38. Accessory pathway and atrio-ventricular reentrant tachycardia<br>39. Atrioventricular nodal reentrant tachycardia<br>40. Inappropriate sinus tachycardia<br>41. Ablation of nodal and atrio-ventricular accessory pathways</p> <p>Atrial Fibrillation<br>42. Rate control of atrial fibrillation<br>43. Cardioversion<br>44. Catheter ablation of atrial fibrillation<br>45. Demographics and procedural data differences of AF ablation<br>46. Monitoring and follow-up after atrial fibrillation ablation<br>47. Thromboembolic risk and anticoagulation therapy<br>48. Quality of life with AF </p> <p>Myocardial Ischemia and Infarction<br>49. Electrocardiographic manifestation of suspected acute coronary syndromes <br>50. Acute MI and cardiogenic shock arrhythmias<br>51. Arrhythmias of subacute phase of MI<br>52. Sex-specific arrhythmia risk of post-MI follow-up<br>53. Sex Differences in Intensive Care Unit Electrocardiographic Alarms<br>54. Predictive value of admission electrocardiography in heart failure</p> <p>Ventricular Tachycardias<br>55. Ventricular arrhythmias associated with structural heart disease<br>56. Catheter ablation of ventricular arrhythmias associated with structural heart disease<br>57. Idiopathic ventricular arrhythmias<br>58. Mapping and catheter ablation of idiopathic ventricular arrhythmias</p> <p>Electrophysiology in Pregnancy<br>59. Hormonal and autonomic electrophysiologic effects of pregnancy<br>60. Supraventricular tachycardias during pregnancy<br>61. Atrial fibrillation during pregnancy<br>62. Ventricular tachyarrhythmia during pregnancy<br>63. Pregnancy in congenital long QT and Brugada syndrome patients<br>64. Pregnancy and implanted devices<br>65. Fetal arrhythmia in intrahepatic cholestasis of pregnancy</p> <p>Sudden Cardiac Death<br>66. Demographics and epidemiology<br>67. Sudden Infant death syndrome<br>68. Cardiac risk in the young<br>69. Sex-specific mechanisms of sudden cardiac death<br>70. Sex-specific risk assessment of sudden cardiac death</p> <p>Drug Therapy<br>71. Safety and efficacy of antiarrhythmic drugs<br>72. Dose responses in acquired long QT syndrome<br>73. Acquired long QT syndrome and sex hormones<br>74. Management of arrhythmias in pregnancy</p> <p>Device Based Therapies<br>75. Antibradycardia pacing<br>76. Primary and secondary prevention of SCD in women<br>77. Utility of Implantable cardioverter-defibrillators<br>78. ICD registries and sex-specific metanalyses<br>79. Clinical experience with the use of CRT in women<br>80. CRT registries and sex-specific metanalyses<br>81. Lead extraction in women<br>82. Quality of life with implanted devices</p> <p>Outlook<br>83. Obstacles for enrolment of women in clinical trials<br>84. Regulatory implications of sex differences in clinical trials</p>